Table of Contents

Original Article

• You have access

  Kinetochore protein MAD1 participates in the DNA damage response through ataxia-telangiectasia mutated kinase-mediated phosphorylation and enhanced interaction with KU80

  Mingming Xiao, Xuesong Li, Yang Su, Zhuang Liu, Yamei Han, Shuai Wang, Qinghua Zeng, Hong Liu, Jianwei Hao and Bo Xu

  Cancer Biology & Medicine August 2020, 17 (3) 640-651; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0044
• You have access

  Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer

  Keson Trakunram, Pichitpon Chaniad, Sarayut Lucien Geater, Warangkana Keeratichananont, Voravit Chittithavorn, Sumonmal Uttayamakul, Suhaimee Buya, Pritsana Raungrut and Paramee Thongsuksai

  Cancer Biology & Medicine August 2020, 17 (3) 652-663; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0063
• You have access

  TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma

  Yingbin Xie, Luyue Chen, Junhu Zhou, Chao Yang, Can Xu, Xiangyu Fan, Yanli Tan, Yanan Wang, Chunsheng Kang and Chuan Fang

  Cancer Biology & Medicine August 2020, 17 (3) 664-675; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0356
• You have access

  An ATF₂₄ peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment

  Bingtao Zhai, Peng Chen, Wengang Wang, Shuiping Liu, Jiao Feng, Ting Duan, Yu Xiang, Ruonan Zhang, Mingming Zhang, Xuemeng Han, Xiaying Chen, Qiujie Li, Guohua Li, Ying Liu, Xingxing Huang, Wenzheng Zhang, Ting Pan, Lili Yan, Ting Jin, Tian Xie and Xinbing Sui

  Cancer Biology & Medicine August 2020, 17 (3) 676-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0454
• You have access

  An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway

  Xiaotong Zhang, Gengyi Zou, Xiyang Li, Lun Wang, Tianyu Xie, Jin Zhao, Longlong Wang, Shunchang Jiao, Rong Xiang, Haoyu Ye and Yi Shi

  Cancer Biology & Medicine August 2020, 17 (3) 693-706; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0010
• You have access

  SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability via the PI3K/AKT/GSK3β signaling pathway

  Yue Yuan, Yanling Fan, Zicong Gao, Xuan Sun, He Zhang, Zhiyong Wang, Yanfen Cui, Weijie Song, Zhaosong Wang, Fei Zhang and Ruifang Niu

  Cancer Biology & Medicine August 2020, 17 (3) 707-725; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0056
• You have access

  Single-cell RNA-seq reveals the immune escape and drug resistance mechanisms of mantle cell lymphoma

  Liang Wang, Steven Mo, Xin Li, Yingzhi He and Jing Yang

  Cancer Biology & Medicine August 2020, 17 (3) 726-739; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0073
• You have access

  Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation via downregulating frizzled class receptor 10

  Jiongyu Chen, Fan Zhang, Xiaosha Ren, Yahui Wang, Wenhe Huang, Jianting Zhang and Yukun Cui

  Cancer Biology & Medicine August 2020, 17 (3) 740-752; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0219
• You have access

  Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling

  Tingting Qin, Zhujun Liu, Jing Wang, Junling Xia, Shaochuan Liu, Yanan Jia, Hailin Liu and Kai Li

  Cancer Biology & Medicine August 2020, 17 (3) 753-767; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0024
• You have access

  Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer

  Runsen Jin, Chengming Liu, Sufei Zheng, Xinfeng Wang, Xiaoli Feng, Hecheng Li, Nan Sun and Jie He

  Cancer Biology & Medicine August 2020, 17 (3) 768-781; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0121
• You have access

  Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library

  Yuanzhong Wu, Liwen Zhou, Zifeng Wang, Xin Wang, Ruhua Zhang, Lisi Zheng and Tiebang Kang

  Cancer Biology & Medicine August 2020, 17 (3) 782-794; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0162
• You have access

  Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study

  Liqiang Wei, Lei Yang, Jin Ye, Jia Cong, Xin Li, Na Yao, Jing Yang, Xueying Cui, Jing Ding, Yiping Wu and Jingwen Wang

  Cancer Biology & Medicine August 2020, 17 (3) 795-804; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0160